Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 13/20 | 0.53 |
| ▸ | CA2 | P00918 | 13/20 | 0.53 |
| ▸ | CA9 | Q16790 | 13/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA3 | P07451 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | CA6 | P23280 | 1/20 | 0.53 |
| ▸ | CA5A | P35218 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.53 |
| ▸ | PDIA6 | Q15084 | 1/20 | 0.43 |
| ▸ | LPL | P06858 | 4/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.41 |
| ▸ | F11 | P03951 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17442284 | 1.00 | CA1 (0.53) | CA1CA2CA9CA12CA3 | |
| SCHEMBL17442381 | 0.89 | CA1 (0.55) | CA1CA2CA9CA12CA3 | |
| SCHEMBL30519252 | 0.89 | CA1 (0.55) | CA1CA2CA9CA12CA3 | |
| SCHEMBL2414637 | 0.86 | CA1 (0.55) | CA1CA2CA9CA12CA3 | |
| SCHEMBL14658432 | 0.85 | L3MBTL1 (0.47) | CA1CA2CA9CA12CA3 | |
| SCHEMBL17442456 | 0.84 | CA1 (0.53) | CA1CA2CA9CA12CA3 | |
| SCHEMBL17442153 | 0.84 | CA1 (0.53) | CA1CA2CA9CA12CA3 | |
| SCHEMBL29021167 | 0.83 | CA1 (0.44) | CA1CA2CA9CA12CA3 | |
| SCHEMBL2414926 | 0.83 | CA1 (0.51) | CA1CA2CA9CA12CA3 | |
| SCHEMBL24168961 | 0.83 | LIPG (0.45) | CA1CA2CA9CA12CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023146513-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |